JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hazbón, M. H.
Right arrow Articles by Wanger, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hazbón, M. H.
Right arrow Articles by Wanger, A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 2000, p. 4599-4603, Vol. 38, No. 12
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Evaluation of Etest for Susceptibility Testing of Multidrug-Resistant Isolates of Mycobacterium tuberculosis†

Manzour Hernando Hazbón,1,* Maria del Socorro Orozco,1 Luz Angela Labrada,1 Rafael Tovar,1 Kristen A. Weigle,2 and Audrey Wanger3

Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM), Cali, Colombia1; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina2; and Department of Pathology and Laboratory Medicine, University of Texas Medical School, Houston, Texas3

Received 7 July 2000/Returned for modification 4 September 2000/Accepted 27 September 2000

To prescribe effective treatment schemes for patients with tuberculosis, more-efficient susceptibility testing techniques for Mycobacterium tuberculosis are needed, especially in regions with multidrug resistance. Etest (AB BIODISK, Solna, Sweden) is a simple technique that provides quantitative drug susceptibility results for M. tuberculosis in 5 to 10 days from a culture grown at low cost. The performance of Etest was compared to that of the reference proportion method, using 95 M. tuberculosis clinical isolates of which 42.1% (40 of 95) were resistant to at least one antibiotic by the reference method. Overall agreement between Etest and the reference method was 98.9% (94 of 95) for detection of multidrug resistance; for resistance to individual drugs, agreement was 97.9% (93 of 95) for rifampin, 96.0% (92 of 95) for ethambutol, 94.7% (90 of 95) for isoniazid, and 85.3% (81 of 95) for streptomycin. This study supports the utility of Etest for timely detection of drug resistance in M. tuberculosis and for use in tuberculosis control programs.

* Corresponding author. Mailing address: CIDEIM. Avenida 1 norte No. 3-03. Cali, Valle, Colombia. Phone: (57 2) 668 21 64. Fax: (57 2) 667 29 89. E-mail: molecular{at}cideim.org.co.

dagger Dedicated to the memory of Luis Ernesto Giraldo.

Journal of Clinical Microbiology, December 2000, p. 4599-4603, Vol. 38, No. 12
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2000 by the American Society for Microbiology. All rights reserved.